Of 29 patients with aortopulmonary transposition with intact ventricular septum who underwent cardiac catheterization as neonates, five subsequently developed increased pulmonary vascular resistance at an early age (7 months to 2'/2 years). The resistance was high in two patients (11.0 and 12.9 units (U)/m2), moderate in one (5.5 U/M2) and mild in two (3.6 and 4.6 U/M2). The two patients with the highest resistances died as a result of the pulmonary vascular obstruction and it was probably a contributing factor in the death of a third patient. The finding of pulmonary vascular obstruction at an early age in five of 29 
PATIENTS WITH AORTOPULMONARY TRANS-
POSITION and a ventricular septal defect (VSD) and/or patent ductus arteriosus (PDA) commonly develop severe pulmonary vascular obstruction at an early age. This association has been demonstrated at cardiac catheterization,1' 2 lung biopsies,2 3 and in necropsy series.2' 4' Similar but less severe pulmonary vascular obstructive changes have been found infrequently at necropsy in infants with aortopulmonary transposition and only an atrial septal defect (ASD),4 and documented rarely at cardiac catheterization.2 In a group of 29 patients with aortopulmonary transposition and ASD, 27 of whom we have recatheterized, five children aged 7 months to 21/2 years demonstrated early development of pulmonary vascular obstruction. In two of these patients the obstruction was severe and led to early deaths, and in a third patient, probably contributed to a postoperative death. Possible factors contributing to the early development of pulmonary vascular obstruction in these patients are discussed as are the problems inherent in the determination of pulmonary vascular resistance in patients with aortopulmonary transposition.
Materials and Methods
During the period July 1966 to June 1974, 86 infants with simple aortopulmonary transposition (i.e., without associated single ventricle or atrioventricular valve abnormalities) underwent cardiac catheterization at the University of California Medical Center, San Francisco. Twentynine of these patients had an intact ventricular septum and either a minute patent ductus arteriosus (17 patients) or a closed ductus (12 patients) at the initial catheterization. A small PDA was still present at recatheterization in only one patient. Patients with a moderate size or large PDA or associated abnormalities such as total anomalous pulmonary venous connection at the initial catheterization were excluded from the study group as were patients who had pulmonary outflow gradients greater than 30 mm Hg or peripheral pulmonic stenosis at repeat catheterization. The pulmonary artery was entered in 14 of the 27 recatheterized patients. Of these 14 patients, two had markedly increased (greater than 10 U/in2), one had moderately increased (5-10 U/in2), and two had mildly increased (3-5 U/in2) calculated pulmonary vascular resistance (table 1) . Nine patients had normal calculated pulmonary vascular resistance (less than 3U m2). Of the 13 patients in whom the pulmonary artery was not entered, ten had left ventricular systolic pressures less than 45 mm Hg, and were considered to have normal pulmonary vascular resistance. The other three had left ventricular systolic pressures of 50 mm Hg, 50 mm Hg, and 65 mm Hg, respectively; however two of the three patients had cineangiographic evidence of left ventricular outflow obstruction and one had evidence of parenchymal lung disease at the time of the study. As pulmonary arterial pressures were not obtained, mildly increased pulmonary vascular resistance could not be excluded in these three patients and they are not included in the group of patients with pulmonary vascular obstruction. This may result as an underestimate of the incidence of this problem.
Branch pulmonary arterial and pulmonary venous stenosis were not sources of error in the assessment of pulmonary vascular resistance in the five patients with elevated resistance. Although both branch pulmonary arteries were not entered in each of the five cases, none had angiographic evidence of branch or peripheral pulmonic stenosis. One or more pulmonary veins were entered at recatheterization in four cases and there was no evidence of pulmonary vein stenosis. The fifth showed no pulmonary vein stenosis at necropsy. Pulmonary venous oxygen and carbon dioxide tensions were normal in four cases and were evidence against pulmonary disease and/or hypoventilation due to sedation as the cause of increased pulmonary vascular resistance. Arterial Pco2 was normal in the fifth patient. .0 creased pulmonary vascular resistance with minimal responsiveness to oxygen and tolazoline. Both patients had moderately severe systemic arterial hypoxemia and pulmonary arterial hypertension. It is of particular interest that patient #2 was first restudied at age 14 months and was found to have normal pulmonary arterial pressures and a mildly elevated calculated pulmonary vascular resistance (3.8 units/ m2 (fig. 1 ). The measured pulmonary arteriovenous oxygen saturation difference would be falsely low and the calculated pulmonary flow greater than actual flow. Although it would seem that bronchial contribution to pulmonary flow is too small to produce a major discrepancy, figure 1 shows an example in which a bronchial contribution of only 10% results in a 40% overestimate of pulmonary flow. Consequently, calculated pulmonary vascular resistances are minimum values and marginally elevated resistance values assume even greater significance. Limited bronchial flow has been noted in patients with aortopulmonary transposition without severe pulmonary stenosis or pulmonary were among these nine patients.
Measurement of pulmonary blood flow by indicator dilution methods in aortopulmonary transposition also has its problems. The use of dyes as indicators is technically difficult as two venous catheters are required; there may be marked streaming inequities and the indicator dilution curves show early and very pronounced recirculation. The latter is less of a problem with thermodilution techniques and only one catheter is required; however, streaming may still introduce considerable error. With pulmonary arterial sampling, both dilution methods underestimate total pulmonary flow by a volume equal to the bronchial flow and, therefore, the error is considerably less than with the Fick technique. With pulmonary venous sampling, dye dilution curves would include bronchial flow.
Pulmonary flows derived from angiographic volume measurements show considerable variation among patients with aortopulmonary transposition with intact septum.'6 The outputs have been shown to be comparable to outputs measured by thermodilution and both are generally smaller than Fick estimates.'2 Angiographic volume measurements do not include bronchial contribution and the underestimate is equal to the bronchial contribution. Serial measurements (e.g., after oxygen and tolazoline) are not desirable because of the large volumes of contrast necessary.
In summary, the bronchial contribution to pulmonary flow introduces an error in the calculated pulmonary flow. For a given set of bronchial and pulmonary flows, the magnitude and direction of error depends upon the method of measurement. Another obvious source of error is the use of assumed oxygen consumptions in the Fick method. Although we currently measure oxygen consumption by a hood collection technique,'7 each of the five patients were studied prior to its use. The use of the predictive equations of Fixler and coworkers6 as compared with Cayler and coworkers'8 resulted in only minor differences in the calculated pulmonary vascular resistances found at the last catheterization of the five patients with increased pulmonary vascular resistance (-4.7%, -1.3%, 0%, +10.7% and +15.7%, respectively). The data of Fixler and coworkers suggests that errors of greater than 30% were most unusual using their predictive equations.
The cause of early pulmonary vascular obstruction in these patients is unknown. Aortopulmonary transposition with intact ventricular septum is the only congenital cardiac lesion with a combination of initially normal pulmonary arterial pressures, increased calculated pulmonary blood flow, and a high hematocrit. Hematocrit levels above 50% result in a progressive increase in viscosity or resistance to pulmonary blood flow,"9 20 an effect which is accentuated by increasing blood flow.'9 The increased shear forces acting on the endothelial surface of the small pulmonary vessels may cause progressive intimal changes with eventual obliteration of the vessel lumen. Similar vascular changes occur in patients with atrial septal defects at a later age, and the earlier development of these changes in patients with aortopulmonary transposition and intact ventricular septum may be a reflection of differences in hematocrit levels between the two groups. Preferential blood flow to the right lung in patients with transposition has been documented2' and it has been suggested that such flow inequities might add to the early development of pulmonary vascular obstruction.
We do not know whether early surgical management will delay or halt progression of pulmonary vascular obstruction; the postoperative course in one of our patients (#5) suggests that it may. However, this patient had the lowest resistance and was the youngest of the five with a raised pulmonary vascular resistance, so that general conclusions from her course are not warranted. The development of marked pulmonary vascular obstruction following Mustard's procedure has been reported in three patients whose pulmonary artery pressures and pulmonary vascular resistance were normal prior to surgery. 2, 22 
